Screener
Royalty Pharma RPRX Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's net debt?
- Royalty Pharma (RPRX) reported net debt of $8.15B in Q2 2026.
- How has Royalty Pharma's net debt changed year-over-year?
- Royalty Pharma's net debt increased by 10.3% year-over-year, from $7.39B to $8.15B.
- What is the long-term trend for Royalty Pharma's net debt?
- Over 5 years (2020 to 2025), Royalty Pharma's net debt has grown at a 11.7% compound annual growth rate (CAGR), from $4.81B to $8.35B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Royalty Pharma's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude